Breaking News
-
APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
JSR Life Sciences Expands European Footprint
Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.10.20.20
-
Breaking News | Clinical Trials
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin
Phase 2 trial will commence during the first quarter of 2021.Contract Pharma Staff 10.20.20
-
Breaking News | Clinical Trials | Collaborations & Alliances
Cytocom and Cleveland Biolabs Merge
Combine their businesses in an all-stock transaction.Contract Pharma Staff 10.20.20
-
Breaking News | Trials & Filings
Valneva’s Chikungunya Vax Granted PRIME Designation
Becomes the first company worldwide to advance a chikungunya vaccine candidate into Phase III.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Rznomics Ink License Agreement for CAP Technology
Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.10.20.20
-
Breaking News | Clinical Trials
Mereo Makes Leadership Changes
Appoints CFO and SVP, regulatory affairs.Contract Pharma Staff 10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.10.20.20
-
Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
CordenPharma Colorado Completes Highly Potent API Lab Expansion
Capable of handling highly potent compounds with an OEL as low as 1ng/m3.Contract Pharma Staff 10.19.20
-
Bio News | Breaking News | Facilities | Industry News | Parenterals
INCOG BioPharma Launches Central Indiana Ops
New CDMO is investing roughly $60 million to construct and equip a 60,000-square-foot facility in Fishers.Contract Pharma Staff 10.19.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Antegene, WuXi Biologics Enter Oncology R&D Alliance
To collaborate on the development and production of novel drugs, and jointly promote the R&D of innovative oncology therapies in China.Contract Pharma Staff 10.19.20
-
Breaking News | Cold Chain Management | Collaborations & Alliances | Industry News
BioLife Solutions Secures $2.7 Million Contract
Will provide cold chain management and storage of COVID-19 vaccines.Contract Pharma Staff 10.19.20
-
Breaking News | Industry News
Arcinova Installs R1000 Robotic Capsule Filler
Increases production to 1000 units per hour, while maintaining the same level of operator labor.Contract Pharma Staff 10.19.20
-
Breaking News | Financial Reports
Financial Report: Johnson & Johnson
Pharmaceutical sales were up 5% in the quarter to $11.4 billion.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AstraZeneca, U.S. Govt. Enter $486M COVID-19 Antibody Agreement
Funding will be used for two Phase III trials and related development and manufacturing activities for the supply of AZD7442 doses in the U.S.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Industry News
J&J Pauses All Trials Evaluating COVID-19 Vax Candidate
Temporarily pauses further dosing in all COVID-19 vaccine candidate trials to investigate an an unexplained illness.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients
ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.Contract Pharma Staff 10.16.20
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
GSK to Sell Poznań Manufacturing Site to Delpharm
The CDMO acquires all facilities and gains approximately 700 manufacturing employees.Contract Pharma Staff 10.15.20
-
Breaking News | Industry News | Promotions & Moves
Vigene Biosciences Appoints COO
Molly McGlaughlin brings 27 years of experience in biologics manufacturing and development.Contract Pharma Staff 10.15.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
The Discovery Labs Appoints President and COO
Taps former Lonza Exec, Jeorg Ahlgrimm.Contract Pharma Staff 10.15.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Thermo Fisher to Expand Sterile Filling Capacity with New Facility in Singapore
Investment supports global health and preparedness in the Asia-Pacific region.10.15.20
